StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Mankind Pharma Limited
NSE:MANKIND.NS
Sector
Location
Market Cap
USD 12.38 B
Share Price
USD 30.00
Avg Daily Volume
441,236
Change (1 day)
1.14%
Change (1 year)
18.45%
Change (YTD)
-10.83%
Mankind Pharma Limited Interest Coverage Ratio for the year ending March 31, 2025: 5.58
Mankind Pharma Limited Interest Coverage Ratio is 5.58 for the year ending March 31, 2025, a -93.38% change year over year. Interest coverage ratio assesses earnings' ability to cover interest expenses; higher ratios signal lower risk.
-
Mankind Pharma Limited Interest Coverage Ratio for the year ending March 31, 2024 was 84.31, a 120.44% change year over year.
-
Mankind Pharma Limited Interest Coverage Ratio for the year ending March 31, 2023 was 38.25, a 7.73% change year over year.
-
Mankind Pharma Limited Interest Coverage Ratio for the year ending March 31, 2022 was 35.50, a -59.63% change year over year.
-
Mankind Pharma Limited Interest Coverage Ratio for the year ending March 31, 2021 was 87.95, a 33.72% change year over year.
Competitors
Zydus Lifesciences Limited
USD 11.40
ZYDUSLIFE.NS
+0.05
0.48%
Ipsen S.A.
USD 123.54
IPN.PA
-3.05
-2.41%
PT Kalbe Farma Tbk.
USD 0.10
KLBF.JK
+0.01
5.98%
China Resources Double-Crane Pharmaceutical Co.,Ltd.
USD 2.60
600062.SS
-0.03
-1.09%
Eli Lilly and Company
USD 793.01
LLY
+2.36
0.30%
AbbVie Inc.
USD 192.45
ABBV
-2.55
-1.31%
Novo Nordisk A/S
USD 68.61
NOVO-B.CO
-2.69
-3.77%
Roche Holding AG
USD 343.65
RO.SW
-5.43
-1.55%
Novartis AG
USD 120.78
NOVN.SW
-3.44
-2.77%
Abbott Laboratories
USD 132.02
ABT
-1.58
-1.18%
AstraZeneca PLC
USD 140.89
AZN.L
-3.33
-2.31%
Merck & Co., Inc.
USD 83.36
MRK
-0.66
-0.79%
Thermo Fisher Scientific Inc.
USD 434.86
TMO
+4.13
0.96%
Amgen Inc.
USD 295.27
AMGN
-5.10
-1.70%
Pfizer Inc.
USD 25.65
PFE
-0.13
-0.50%
Gilead Sciences, Inc.
USD 109.64
GILD
-4.90
-4.28%
Vertex Pharmaceuticals Incorporated
USD 468.85
VRTX
-10.68
-2.23%
Sanofi
USD 97.05
SAN.PA
-1.42
-1.44%
Bristol-Myers Squibb Company
USD 46.86
BMY
-1.66
-3.42%
GSK plc
USD 18.99
GSK.L
-0.75
-3.81%
Key Data
| Date | Interest Coverage Ratio | Return on Capital Employed (ROCE) | Return on Equity (ROE) | Return on Assets (ROA) |
|---|
Competitors
Zydus Lifesciences Limited
USD 11.40
ZYDUSLIFE.NS
+0.05
0.48%
Ipsen S.A.
USD 123.54
IPN.PA
-3.05
-2.41%
PT Kalbe Farma Tbk.
USD 0.10
KLBF.JK
+0.01
5.98%
China Resources Double-Crane Pharmaceutical Co.,Ltd.
USD 2.60
600062.SS
-0.03
-1.09%
Eli Lilly and Company
USD 793.01
LLY
+2.36
0.30%
AbbVie Inc.
USD 192.45
ABBV
-2.55
-1.31%
Novo Nordisk A/S
USD 68.61
NOVO-B.CO
-2.69
-3.77%
Roche Holding AG
USD 343.65
RO.SW
-5.43
-1.55%
Novartis AG
USD 120.78
NOVN.SW
-3.44
-2.77%
Abbott Laboratories
USD 132.02
ABT
-1.58
-1.18%
AstraZeneca PLC
USD 140.89
AZN.L
-3.33
-2.31%
Merck & Co., Inc.
USD 83.36
MRK
-0.66
-0.79%
Thermo Fisher Scientific Inc.
USD 434.86
TMO
+4.13
0.96%
Amgen Inc.
USD 295.27
AMGN
-5.10
-1.70%
Pfizer Inc.
USD 25.65
PFE
-0.13
-0.50%
Gilead Sciences, Inc.
USD 109.64
GILD
-4.90
-4.28%
Vertex Pharmaceuticals Incorporated
USD 468.85
VRTX
-10.68
-2.23%
Sanofi
USD 97.05
SAN.PA
-1.42
-1.44%
Bristol-Myers Squibb Company
USD 46.86
BMY
-1.66
-3.42%
GSK plc
USD 18.99
GSK.L
-0.75
-3.81%